Navigation Links
Video: RE-LY Trial Met Primary Outcome for Reducing Incidence of Stroke or Systemic Embolism in Non-valvular Atrial Fibrillation Patients
Date:8/30/2009

RIDGEFIELD, Conn., Aug. 30 /PRNewswire/ -- Boehringer Ingelheim today announced that results from the RE-LY(R) (Randomized Evaluation of Long-Term Anticoagulant Therapy, Warfarin, Compared with Dabigatran) study -- the largest atrial fibrillation (AF) outcomes trial ever conducted(1) (18,113 patients in 44 countries worldwide) -- were presented for the first time at the European Society of Cardiology Congress and published online in the New England Journal of Medicine.(2) The primary objective of RE-LY was to assess the safety and efficacy of the investigational oral direct thrombin inhibitor, dabigatran etexilate against warfarin (titrated to INR 2.0 to 3.0) for the prevention of stroke in patients with non-valvular atrial fibrillation.(1)

To view the Multimedia News Release, go to: http://www.prnewswire.com/mnr/boehringeringelheim/39821/

The RE-LY study results have shown:

  • Both doses of dabigatran etexilate were non-inferior to warfarin on the primary endpoint of reducing the incidence of stroke (including hemorrhagic) and systemic embolism (p < 0.001)(2)
  • Dabigatran etexilate 150 mg BID was superior to warfarin in reducing the incidence of stroke (including hemorrhagic) and systemic embolism by 34 percent (RR 0.66, 95% CI, 0.53-0.82, p < 0.001)(2)
  • There was no significant difference in the rate of major bleeding for dabigatran 150 mg BID compared to warfarin (3.11 percent/year, 3.36 percent/year, respectively p=0.31)(2)
  • The rate of major bleeding with dabigatran etexilate 110 mg BID (2.71 percent/year) was 20 percent lower compared to warfarin (p=0.003)(2)

Also presented and published today were results in other outcomes from t
'/>"/>

SOURCE Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Video: Phase III Head to Head Trial Showed Ticagrelor Reduced Cardiovascular Death and Heart Attacks Over Clopidogrel in Acute Coronary Syndromes Patients
2. Video: AstraZeneca Traveling Exhibit Helps Americans Understand and Manage Bipolar Depression
3. Video: School Nurses Tackle Low Parental Awareness of Meningitis Via Comprehensive National Public Education Campaign
4. Video: Sounds of Pertussis Campaign Urges Adults to Take Action During National Immunization Awareness Month
5. Video: Schering-Plough Announces FDA Approval of SAPHRIS(R) (asenapine) for Acute Treatment of Schizophrenia In Adults and Manic or Mixed Episodes of Bipolar I Disorder With or Without Psychotic Features In Adults
6. Video: FDA Approves EMBEDA(TM) For Management of Moderate to Severe Chronic Pain
7. Video: Provectus Pharmaceuticals Updates Shareholders On 2009 Year-To-Date Accomplishments
8. Video: People With Pain, Healthcare Providers Sound Off in First-Ever Online Talk Show About Pain
9. Video: American Dental Association Statement: Food and Drug Administration Action on Dental Amalgam
10. Video: Sodexo Takes on Childhood Obesity in School Cafeterias
11. Video: What Are Those Little Red Bumps?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2015)... Wilmington, DE (PRWEB) , ... July 31, 2015 ... ... long term care client base, with the recent implementation of Microsoft Dynamics GP ... provider in the industry, Intellitec is now supporting senior living communities in 16 ...
(Date:7/30/2015)... ... ... Dale Sky Jones, Executive Chancellor of Oaksterdam University , the first cannabis ... at the Caribe Royal All Suites Hotel and Convention Center in Orlando, Florida, October ... medical cannabis expo in the country and this year’s expo will be the first ...
(Date:7/30/2015)... ... July 30, 2015 , ... World Patent Marketing, a vertically ... invention that can help people during emergencies. , "The worldwide mobile health market ... Director of World Patent Marketing. "Currently, there are about 97,000 mobile health apps ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... The connection between a healthy head of ... The loss of a full head of hair can have a devastating impact on ... person is perceived in the work place, the consequences of hair loss are not to ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... region, is the recipient of three awards in the Service Industry Advertising Awards ... created for Choptank Transport, KRM Development Corporation and University of Maryland Shore Regional ...
Breaking Medicine News(10 mins):Health News:Intellitec Solutions Expands Long term Care ERP Offerings to Maine 2Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 2Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 3Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 4Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 5Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 2Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 3Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 4Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 5Health News:New Study Shows the Link between Hair Restoration and Healthy Self-Image 2Health News:Mullin/Ashley Associates Takes Home Wins for Three Clients in the Service Industry Advertising Awards Annual Competition 2Health News:Mullin/Ashley Associates Takes Home Wins for Three Clients in the Service Industry Advertising Awards Annual Competition 3
... Oct. 17 ImClone Systems,Incorporated (Nasdaq: IMCL ... ),today announced that they have established an agreement ... ERBITUX(R) (cetuximab) in,Japan. Under the terms of the ... collaborate on a joint effort to develop and,following ...
... Bickley wins CBay,s ,Keys to Medical ... Records Success, sweepstakes, ... transcription and healthcare BPO services, today announced the winner of,its ... and Exhibit in Philadelphia. (Photo: http://www.newscom.com/cgi-bin/prnh/20071017/NEW009 ) ...
... following is a,transcript of remarks by President Bush, Senator ... afternoon. Thanks for coming. Welcome to the Rose,Garden. I ... their commission for joining me today. Welcome. I ... and Acting,Secretary Mansfield -- with service members who were ...
... At the U.S. Food and Drug,Administration,s ... today, the majority of members voted to ... Pharmaceuticals, non-calcium FOSRENOL(R),(lanthanum carbonate), to treat hyperphosphatemia ... chronic kidney disease (CKD) Stage 4 patients.,Currently, ...
... DEXTER, Mich., Oct. 16 ReCellular, Inc., ... used wireless phones and,accessories, today announced it ... Cellular ( http://www.consumercellular.com ), one of,the nation,s ... to,collect wireless handsets for recycling from their ...
... (NASDAQ: ASPV ; TSX: ASV) today announced ... million for the third,quarter of 2007 compared to ... 2006. As previously announced, Aspreva will release ... The Company will hold a conference,call and webcast ...
Cached Medicine News:Health News:ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan 2Health News:ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan 3Health News:ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan 4Health News:ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan 5Health News:ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan 6Health News:ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan 7Health News:CBaySystems Gives Away 2008 Honda Civic at AHIMA 2007 2Health News:Remarks by President Bush, Senator Bob Dole and Secretary Donna Shalala on Commission on Care for America's Returning Wounded Warriors Report Implementation 2Health News:Remarks by President Bush, Senator Bob Dole and Secretary Donna Shalala on Commission on Care for America's Returning Wounded Warriors Report Implementation 3Health News:Remarks by President Bush, Senator Bob Dole and Secretary Donna Shalala on Commission on Care for America's Returning Wounded Warriors Report Implementation 4Health News:Remarks by President Bush, Senator Bob Dole and Secretary Donna Shalala on Commission on Care for America's Returning Wounded Warriors Report Implementation 5Health News:Remarks by President Bush, Senator Bob Dole and Secretary Donna Shalala on Commission on Care for America's Returning Wounded Warriors Report Implementation 6Health News:Remarks by President Bush, Senator Bob Dole and Secretary Donna Shalala on Commission on Care for America's Returning Wounded Warriors Report Implementation 7Health News:Remarks by President Bush, Senator Bob Dole and Secretary Donna Shalala on Commission on Care for America's Returning Wounded Warriors Report Implementation 8Health News:FDA Advisory Committee Votes in Favor of Earlier Use of Phosphate Binders in Stage 4 Kidney Disease Patients With Hyperphosphatemia 2Health News:FDA Advisory Committee Votes in Favor of Earlier Use of Phosphate Binders in Stage 4 Kidney Disease Patients With Hyperphosphatemia 3Health News:FDA Advisory Committee Votes in Favor of Earlier Use of Phosphate Binders in Stage 4 Kidney Disease Patients With Hyperphosphatemia 4Health News:FDA Advisory Committee Votes in Favor of Earlier Use of Phosphate Binders in Stage 4 Kidney Disease Patients With Hyperphosphatemia 5Health News:FDA Advisory Committee Votes in Favor of Earlier Use of Phosphate Binders in Stage 4 Kidney Disease Patients With Hyperphosphatemia 6Health News:FDA Advisory Committee Votes in Favor of Earlier Use of Phosphate Binders in Stage 4 Kidney Disease Patients With Hyperphosphatemia 7Health News:ReCellular Named Exclusive Cell Phone Recycling Partner for Consumer Cellular 2Health News:ReCellular Named Exclusive Cell Phone Recycling Partner for Consumer Cellular 3Health News:Aspreva Announces Preliminary Revenues for Third Quarter 2007 2Health News:Aspreva Announces Preliminary Revenues for Third Quarter 2007 3Health News:Aspreva Announces Preliminary Revenues for Third Quarter 2007 4
(Date:7/30/2015)... 30, 2015 Mettler-Toledo International Inc. (NYSE: ... Provided below are the highlights: , Sales ... with the prior year. Reported sales decreased 4% as ... , Net earnings per diluted share as reported ... period. Adjusted EPS was $2.80 , an increase ...
(Date:7/30/2015)... July 30, 2015 IRIDEX Corporation (NASDAQ: ... second quarter 2015 financial results after the market closes ... with the release, the Company will host a conference ... Eastern Time on Thursday, August 6, 2015 ... other business developments. Interested parties may access ...
(Date:7/30/2015)... 30, 2015  Tandem Diabetes Care®, Inc. (NASDAQ: ... manufacturer of the t:slim® and t:flex™ Insulin Pumps, ... Development Agreements with Dexcom, Inc. to allow the ... the Dexcom G5 and G6 continuous glucose monitoring ... pump platform with Dexcom,s future CGM systems is ...
Breaking Medicine Technology:Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2015 Results 14IRIDEX Announces Second Quarter 2015 Conference Call and Release Date 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3
... Way for Commercialization in the European ... ... Inc., a,medical device company developing systems for Enabling Regenerative,Medicine(TM), announced today that ... The MarrowMiner,System is a minimally invasive device used to harvest adult stem ...
... of, a Drug Target Function. A Study Performed by Sidec and ... Two Major Conformations ... Have Been Identified, STOCKHOLM, ... direct structural evidence of the molecular mechanism,of the Synaptic Vesicle protein ...
Cached Medicine Technology:StemCor Systems Receives CE Mark for MarrowMiner(TM) System for Bone Marrow Collection 2The First Direct Structural Evidence of SV2A has Been Revealed Thanks to Protein Tomography(TM), and Published in BBRC 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: